Moleculin Biotech, Inc.
NASDAQ:MBRX
2.36 (USD) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 23.55 | 43.145 | 70.903 | 15.173 | 10.735 | 7.134 | 7.714 | 5.007 | 0.028 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 23.55 | 43.145 | 70.903 | 15.173 | 10.735 | 7.134 | 7.714 | 5.007 | 0.028 |
| Net Receivables
| 0.099 | 0.022 | 0.045 | 0.001 | 0.011 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | -0.022 | -0.045 | 1.86 | 2.209 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 2.624 | 2.451 | 1.594 | 0.164 | 0.529 | 0.84 | 0.588 | 0.215 | 0 |
| Total Current Assets
| 26.273 | 45.596 | 72.497 | 17.198 | 13.484 | 7.974 | 8.302 | 5.222 | 0.028 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 0.796 | 0.678 | 0.445 | 0.685 | 0.603 | 0.463 | 0.033 | 0.023 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 11.148 | 11.148 | 11.148 | 11.148 | 11.148 | 11.148 | 11.148 | 11.148 | 0 |
| Goodwill and Intangible Assets
| 11.148 | 11.148 | 11.148 | 11.148 | 11.148 | 11.148 | 11.148 | 11.148 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0.129 | 0 | 0 | 0 | 0 | 0.003 |
| Tax Assets
| 0 | 0 | 0 | -0.117 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| -0 | 0 | 0 | -0.012 | 0 | 0 | 0 | 0 | -0 |
| Total Non-Current Assets
| 11.944 | 11.826 | 11.593 | 11.833 | 11.751 | 11.611 | 11.181 | 11.171 | 0.003 |
| Total Assets
| 38.217 | 57.422 | 84.09 | 29.031 | 25.235 | 19.585 | 19.483 | 16.393 | 0.028 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 2.498 | 4.819 | 1.364 | 1.129 | 2.153 | 1.246 | 0.81 | 0.399 | 0.235 |
| Short Term Debt
| 0.1 | 0.116 | 0.096 | 0.118 | 0.103 | 0 | 0 | 0.296 | 0.45 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 1.15 | 0 | 0 | -0.399 | -0.235 |
| Other Current Liabilities
| 4.217 | -0.116 | 2.162 | 1.673 | 0.164 | 2.632 | 1.405 | 1.049 | 0.323 |
| Total Current Liabilities
| 6.815 | 4.819 | 3.622 | 2.92 | 3.57 | 3.878 | 2.215 | 1.345 | 0.773 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 0.474 | 0.335 | 0.063 | 0.159 | 0.276 | 0 | 0 | 0 | 0.45 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0.107 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 4.855 | 0.077 | 1.412 | 8.192 | 5.818 | 1.328 | 0.15 | 0.088 | 0 |
| Total Non-Current Liabilities
| 5.329 | 0.412 | 1.475 | 8.351 | 6.094 | 1.435 | 0.15 | 0.088 | 0.45 |
| Total Liabilities
| 12.144 | 5.231 | 5.097 | 11.271 | 9.664 | 5.313 | 2.365 | 1.433 | 0.773 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.003 |
| Common Stock
| 0.033 | 0.029 | 0.029 | 0.069 | 0.046 | 0.029 | 0.021 | 0.012 | 0.007 |
| Retained Earnings
| -131.604 | -101.835 | -72.81 | -56.916 | -39.561 | -26.356 | -14.48 | -4.675 | -0.748 |
| Accumulated Other Comprehensive Income/Loss
| -0.009 | 0.012 | 0.041 | 0.065 | 0.031 | 0.035 | -0 | -0 | -0.003 |
| Other Total Stockholders Equity
| 157.653 | 153.985 | 151.733 | 74.542 | 55.055 | 40.564 | 31.577 | 19.623 | -0.003 |
| Total Shareholders Equity
| 26.073 | 52.191 | 78.993 | 17.76 | 15.571 | 14.272 | 17.118 | 14.96 | -0.745 |
| Total Equity
| 26.073 | 52.191 | 78.993 | 17.76 | 15.571 | 14.272 | 17.118 | 14.96 | -0.745 |
| Total Liabilities & Shareholders Equity
| 38.217 | 57.422 | 84.09 | 29.031 | 25.235 | 19.585 | 19.483 | 16.393 | 0.028 |